Hunting Hill Global Capital, LLC Revance Therapeutics, Inc. Transaction History

Hunting Hill Global Capital, LLC

  • $101 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024
BUY
$2.34 - $4.73 $34,402 - $69,540
14,702 Added 34.58%
57,222 $147,000
Q1 2024

May 15, 2024
SELL
$4.65 - $9.31 $33,131 - $66,333
-7,125 Reduced 14.35%
42,520 $209,000
Q4 2023

Feb 14, 2024
SELL
$5.81 - $11.2 $82,013 - $158,099
-14,116 Reduced 22.14%
49,645 $436,000
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $731,338 - $1.6 Million
63,761 New
63,761 $731,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Hunting Hill Global Capital, LLC Portfolio

Follow Hunting Hill Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email